TrialBioMed research international2014

FOXP3 transcription factor: a candidate marker for susceptibility and prognosis in triple negative breast cancer.

Leandra Fiori Lopes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.